We are pleased and proud to announce that our researcher Dr Federica Rizzo has discussed her post-doc dissertation Development of a molecular therapeutic strategy for CMT2A based on in vitro stem cell models about therapeutic research project with cell stam sponsord by Progetto Mitofusina 2, with great success. As Federica says: “This study contributed to deepen the knowledge about disease molecular mechanisms, generating an in vitro model of CMT2A by patient-specific iPSCs, and to identify a possible therapeutic strategy for CMT2A”.